Lightbridge Provides Business Update and Announces First Quarter 2022 Financial Results

Conference Call on Thursday, May 12, 2022, at 4pm ET

Reston, Virginia, UNITED STATES

RESTON, Va., May 11, 2022 (GLOBE NEWSWIRE) -- Lightbridge Corporation (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced financial results for the first quarter ended March 31, 2022 and provided an update on the Company's continued progress.

Seth Grae, President & Chief Executive Officer of Lightbridge Corporation, commented, “Our first quarter saw momentum continue to build related to advancing our fuel development activities. We continue to make progress with our work at Pacific Northwest National Laboratory (PNNL) from our second voucher from the Gateway for Accelerated Innovation in Nuclear (GAIN) program, focused on the manufacturing process for Lightbridge Fuel™. At the same time, we are actively engaging in negotiations with the U.S. Department of Energy’s (DOE), a benefit of our strong working relationship, as well as the private sector, for additional scopes of work that will take Lightbridge Fuel closer to commercialization.”

Financial Highlights

The Company maintained a strong working capital position at March 31, 2022 of approximately $28.2 million and had no debt.

Cash Flows Summary

  • Cash and cash equivalents were $28.2 million at March 31, 2022, compared to $24.7 million at December 31, 2021, an increase of $3.5 million in cash and cash equivalents.

  • Cash used in operating activities was $1.9 million, a decrease from $6.3 million in 2021. This decrease was due primarily to the dissolution of the Enfission joint venture in the first quarter of 2021 and the payment of approximately $4.2 million to Framatome for outstanding invoices for work performed by Framatome and other expenses incurred by Framatome.

  • Cash provided by financing activities increased to $5.4 million in the first quarter of 2022 compared to nil in the first quarter of 2021. This increase was primarily due to an increase in the net proceeds from the issuance of common stock by our at-the-market (ATM) facility in the first quarter of 2022.

Balance Sheet Summary

  • Total assets were $28.9 million and total liabilities were $0.5 million at March 31, 2022. Working capital was $28.3 million at March 31, 2022 versus $24.7 million at December 31, 2021. This was an increase of $3.6 million in working capital for the three months ended March 31, 2022.

  • Stockholders’ equity was $28.4 million at March 31, 2022 as compared to $24.8 million at December 31, 2021.

Operations Summary

  • Total general and administrative expenses increased by approximately $0.1 million for the three months ended March 31, 2022, as compared to the three months ended March 31, 2021. This increase was primarily due to an increase in employee compensation and employee benefits of approximately $0.1 million, an increase in directors’ fees of approximately $0.1 million due to the addition of new board members, an increase in sponsorship fees and promotion fees of approximately $0.1 million due to increased promotion activities, and an increase in stock-based compensation of approximately $0.2 million due to the issuance of restricted stock awards in 2021. These increases were offset by a decrease in professional fees of approximately $0.4 million relating to fees incurred in connection with the arbitration matter in 2021 that were not repeated during the three months ended March 31, 2022.

  • Lightbridge’s total corporate research and development costs for the three months ended March 31, 2022 decreased by approximately $0.1 million, as compared to the three months ended March 31, 2021. There was a decrease in employee compensation and employee benefits of approximately $0.1 million. Lightbridge is working with the U.S. National Laboratories on research and development activities and is negotiating new contracts for additional future scopes of work in 2022.

  • Total net other operating income related to contributed services – research and development was $0.1 million for the three months ended March 31, 2022 and March 31, 2021, with a charge to R&D expenses and a corresponding amount recorded to contributed services – research and development.

  • Net loss for the three months ended March 31, 2022 and March 31, 2021 was $2.0 million.


Lightbridge will host a conference call on Thursday, May 12th at 4:00 pm Eastern Time to discuss the Company's financial results and provide an update on its fuel development activities.

Interested parties can access the conference call by calling 833-519-1295 for U.S. callers or 914-800-3866 for international callers. Please reference Conference ID: 2162086.

The call will be available on the Company’s website via webcast at The conference call will be led by Seth Grae, President and Chief Executive Officer, with other Lightbridge executives available to answer questions.

The webcast will also be archived on the Company’s website. A telephone replay of the call will be available approximately two hours following the call and can be accessed by dialing 855-859-2056 from the U.S. or 404-537-3406 for international callers. Please reference Conference ID: 2162086.

About Lightbridge Corporation

Lightbridge (NASDAQ: LTBR) is an advanced nuclear fuel technology development company positioned to enable carbon-free energy applications that will be essential in preventing climate change. The Company is developing Lightbridge Fuel™, a proprietary next-generation nuclear fuel technology for Small Modular Reactors, as well as existing light-water reactors, which significantly enhances reactor safety, economics, and fuel proliferation resistance. To date, Lightbridge has been awarded twice by the U.S. Department of Energy’s Gateway for Accelerated Innovation in Nuclear program to support development of Lightbridge Fuel™. Lightbridge’s innovative fuel technology is backed by an extensive worldwide patent portfolio. Lightbridge is included in the Russell Microcap® Index. For more information, please visit:

To receive Lightbridge Corporation updates via e-mail, subscribe at

Lightbridge is on Twitter. Sign up to follow @LightbridgeCorp at

For an introductory video on Lightbridge, please visit or click here to watch the video.

Forward Looking Statements

With the exception of historical matters, the matters discussed herein are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the timing and outcome of research and development activities, other steps to commercialize Lightbridge Fuel™ and future governmental support and funding for nuclear energy. These statements are based on current expectations on the date of this news release and involve a number of risks and uncertainties that may cause actual results to differ significantly from such estimates. The risks include, but are not limited to: the Company’s ability to commercialize its nuclear fuel technology; the degree of market adoption of the Company's product and service offerings; the Company’s ability to fund general corporate overhead and outside research and development costs; market competition; our ability to attract and retain qualified employees; dependence on strategic partners; demand for fuel for nuclear reactors, including small modular reactors; the Company's ability to manage its business effectively in a rapidly evolving market; the availability of nuclear test reactors and the risks associated with unexpected changes in the Company’s fuel development timeline; the increased costs associated with metallization of our nuclear fuel; public perception of nuclear energy generally; changes in the political environment; risks associated with the further spread of COVID-19, including the ultimate impact of COVID-19 on people, economies, and the Company’s ability to access capital markets; changes in the laws, rules and regulations governing the Company’s business; development and utilization of, and challenges to, our intellectual property; risks associated with potential shareholder activism; potential and contingent liabilities; as well as other factors described in Lightbridge's filings with the Securities and Exchange Commission. Lightbridge does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise, except as required by law. Readers are cautioned not to put undue reliance on forward-looking statements.

A further description of risks and uncertainties can be found in Lightbridge’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, and in its other filings with the Securities and Exchange Commission, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Statements”, all of which are available at and

Investor Relations Contact:
Matthew Abenante, IRC
Director of Investor Relations
Tel: +1 (646) 828-8710

*** tables follow ***

  March 31,  December 31, 
  2022  2021 
Current Assets      
Cash and cash equivalents $28,226,863  $24,747,613 
Prepaid expenses and other current assets  558,777   113,452 
Total Current Assets  28,785,640   24,861,065 
Other Assets        
Trademarks  101,583   101,583 
Total Assets $28,887,223  $24,962,648 
Current Liabilities        
Accounts payable and accrued liabilities $452,826  $171,521 
Total Current Liabilities  452,826   171,521 
Commitments and contingencies        
Stockholders' Equity        
Preferred stock, $0.001 par value, 10,000,000 authorized shares      
Common stock, $0.001 par value, 13,500,000 authorized, 10,588,674
shares and 9,759,223 shares issued and outstanding at March 31, 2022
and December 31, 2021, respectively
  10,589   9,759 
Additional paid-in capital  167,464,610   161,772,641 
Accumulated deficit  (139,040,802)  (136,991,273)
Total Stockholders' Equity  28,434,397   24,791,127 
Total Liabilities and Stockholders' Equity $28,887,223  $24,962,648 

  Three Month Ended 
  March 31, 
  2022  2021 
Revenue $  $ 
Operating Expenses        
General and administrative  1,913,564   1,782,860 
Research and development  262,823   369,450 
Total Operating Expenses  2,176,387   2,152,310 
Other Operating Income        
Contributed services – research and development  123,353   103,319 
Total Other Operating Income  123,353   103,319 
Total Operating Loss $(2,053,034) $(2,048,991)
Other Income        
Interest income  3,505   3,309 
Foreign currency transaction gain     33,694 
Total Other Income  3,505   37,003 
Net Loss Before Income Taxes  (2,049,529)  (2,011,988)
Income taxes      
Net Loss $(2,049,529) $(2,011,988)
Accumulated Preferred Stock Dividend     (131,434)
Additional deemed dividend on preferred stock due to the beneficial conversion feature     (57,489)
Net Loss Attributable to Common Shareholders $(2,049,529) $(2,200,911)
Net Loss Per Common Share        
Basic and diluted $(0.20) $(0.33)
Weighted Average Number of Common Shares Outstanding – Basic and diluted  10,283,280   6,589,392 

  Three Month Ended 
  March 31, 
  2022  2021 
Operating Activities      
Net Loss $(2,049,529) $(2,011,988)
Adjustments to reconcile net loss from operations to net cash
used in operating activities:
Stock-based compensation  264,936   60,068 
Changes in operating working capital items:        
Prepaid expenses and other current assets  (445,325)  (465,191)
Accounts payable and accrued liabilities  296,305   321,597 
Accrued legal settlement costs     (4,200,000)
Net Cash Used in Operating Activities  (1,933,613)  (6,295,514)
Investing Activities        
Net Cash Used in Investing Activities      
Financing Activities        
Net proceeds from the issuances of common stock  5,412,863    
Net Cash Provided by Financing Activities  5,412,863    
Net Increase (Decrease) in Cash and Cash Equivalents  3,479,250   (6,295,514)
Cash and Cash Equivalents, Beginning of Period  24,747,613   21,531,665 
Cash and Cash Equivalents, End of Period $28,226,863  $15,236,151 
Supplemental Disclosure of Cash Flow Information        
Cash paid during the period:        
Interest paid $  $ 
Income taxes paid $  $ 
Non-Cash Financing Activities:        
Accumulated preferred stock dividend $  $188,923 
Payment of accrued liabilities with common stock $15,000  $69,690